Pharma & Healthcare
Global Non-Animal Softgel Capsules Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 09, 25
- ID: 430608
- Pages: 94
- Figures: 99
- Views: 2
The global Non-Animal Softgel Capsules market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Catalent
Procaps Laboratorios
EuroCaps
Baihe
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
By Type: (Dominant Segment vs High-Margin Innovation)
Carrageenan Softgel
Starch Softgel
Gellan Gum Softgel
By Application: (Core Demand Driver vs Emerging Opportunity)
Health Supplements
Pharmaceutical
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Catalent in Europe)
- Emerging Product Trends: Carrageenan Softgel adoption vs. Starch Softgel premiumization
- Demand-Side Dynamics: Health Supplements growth in China vs. Pharmaceutical potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Non-Animal Softgel Capsules market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Starch Softgel in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Carrageenan Softgel dominance in Europe vs. Starch Softgel demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
Catalent
Procaps Laboratorios
EuroCaps
Baihe
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
By Type: (Dominant Segment vs High-Margin Innovation)
Carrageenan Softgel
Starch Softgel
Gellan Gum Softgel
By Application: (Core Demand Driver vs Emerging Opportunity)
Health Supplements
Pharmaceutical
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Catalent in Europe)
- Emerging Product Trends: Carrageenan Softgel adoption vs. Starch Softgel premiumization
- Demand-Side Dynamics: Health Supplements growth in China vs. Pharmaceutical potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Non-Animal Softgel Capsules market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Starch Softgel in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Carrageenan Softgel dominance in Europe vs. Starch Softgel demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Non-Animal Softgel Capsules Product Scope
1.2 Non-Animal Softgel Capsules by Type
1.2.1 Global Non-Animal Softgel Capsules Sales by Type (2020 & 2024 & 2031)
1.2.2 Carrageenan Softgel
1.2.3 Starch Softgel
1.2.4 Gellan Gum Softgel
1.3 Non-Animal Softgel Capsules by Application
1.3.1 Global Non-Animal Softgel Capsules Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Global Non-Animal Softgel Capsules Market Estimates and Forecasts (2020-2031)
1.4.1 Global Non-Animal Softgel Capsules Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Non-Animal Softgel Capsules Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Non-Animal Softgel Capsules Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Non-Animal Softgel Capsules Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Non-Animal Softgel Capsules Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Non-Animal Softgel Capsules Sales Market Share by Region (2020-2025)
2.2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Region (2020-2025)
2.3 Global Non-Animal Softgel Capsules Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Non-Animal Softgel Capsules Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Non-Animal Softgel Capsules Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Non-Animal Softgel Capsules Market Size and Prospective (2020-2031)
2.4.2 Europe Non-Animal Softgel Capsules Market Size and Prospective (2020-2031)
2.4.3 China Non-Animal Softgel Capsules Market Size and Prospective (2020-2031)
2.4.4 Japan Non-Animal Softgel Capsules Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Non-Animal Softgel Capsules Historic Market Review by Type (2020-2025)
3.1.1 Global Non-Animal Softgel Capsules Sales by Type (2020-2025)
3.1.2 Global Non-Animal Softgel Capsules Revenue by Type (2020-2025)
3.1.3 Global Non-Animal Softgel Capsules Price by Type (2020-2025)
3.2 Global Non-Animal Softgel Capsules Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Non-Animal Softgel Capsules Sales Forecast by Type (2026-2031)
3.2.2 Global Non-Animal Softgel Capsules Revenue Forecast by Type (2026-2031)
3.2.3 Global Non-Animal Softgel Capsules Price Forecast by Type (2026-2031)
3.3 Different Types Non-Animal Softgel Capsules Representative Players
4 Global Market Size by Application
4.1 Global Non-Animal Softgel Capsules Historic Market Review by Application (2020-2025)
4.1.1 Global Non-Animal Softgel Capsules Sales by Application (2020-2025)
4.1.2 Global Non-Animal Softgel Capsules Revenue by Application (2020-2025)
4.1.3 Global Non-Animal Softgel Capsules Price by Application (2020-2025)
4.2 Global Non-Animal Softgel Capsules Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Non-Animal Softgel Capsules Sales Forecast by Application (2026-2031)
4.2.2 Global Non-Animal Softgel Capsules Revenue Forecast by Application (2026-2031)
4.2.3 Global Non-Animal Softgel Capsules Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Non-Animal Softgel Capsules Application
5 Competition Landscape by Players
5.1 Global Non-Animal Softgel Capsules Sales by Players (2020-2025)
5.2 Global Top Non-Animal Softgel Capsules Players by Revenue (2020-2025)
5.3 Global Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Animal Softgel Capsules as of 2024)
5.4 Global Non-Animal Softgel Capsules Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Non-Animal Softgel Capsules, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Non-Animal Softgel Capsules, Product Type & Application
5.7 Global Key Manufacturers of Non-Animal Softgel Capsules, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Non-Animal Softgel Capsules Sales by Company
6.1.1.1 North America Non-Animal Softgel Capsules Sales by Company (2020-2025)
6.1.1.2 North America Non-Animal Softgel Capsules Revenue by Company (2020-2025)
6.1.2 North America Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
6.1.3 North America Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6.1.4 North America Non-Animal Softgel Capsules Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Non-Animal Softgel Capsules Sales by Company
6.2.1.1 Europe Non-Animal Softgel Capsules Sales by Company (2020-2025)
6.2.1.2 Europe Non-Animal Softgel Capsules Revenue by Company (2020-2025)
6.2.2 Europe Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
6.2.3 Europe Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6.2.4 Europe Non-Animal Softgel Capsules Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Non-Animal Softgel Capsules Sales by Company
6.3.1.1 China Non-Animal Softgel Capsules Sales by Company (2020-2025)
6.3.1.2 China Non-Animal Softgel Capsules Revenue by Company (2020-2025)
6.3.2 China Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
6.3.3 China Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6.3.4 China Non-Animal Softgel Capsules Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Non-Animal Softgel Capsules Sales by Company
6.4.1.1 Japan Non-Animal Softgel Capsules Sales by Company (2020-2025)
6.4.1.2 Japan Non-Animal Softgel Capsules Revenue by Company (2020-2025)
6.4.2 Japan Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
6.4.3 Japan Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6.4.4 Japan Non-Animal Softgel Capsules Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Catalent
7.1.1 Catalent Company Information
7.1.2 Catalent Business Overview
7.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Catalent Non-Animal Softgel Capsules Products Offered
7.1.5 Catalent Recent Development
7.2 Procaps Laboratorios
7.2.1 Procaps Laboratorios Company Information
7.2.2 Procaps Laboratorios Business Overview
7.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Products Offered
7.2.5 Procaps Laboratorios Recent Development
7.3 EuroCaps
7.3.1 EuroCaps Company Information
7.3.2 EuroCaps Business Overview
7.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.3.4 EuroCaps Non-Animal Softgel Capsules Products Offered
7.3.5 EuroCaps Recent Development
7.4 Baihe
7.4.1 Baihe Company Information
7.4.2 Baihe Business Overview
7.4.3 Baihe Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Baihe Non-Animal Softgel Capsules Products Offered
7.4.5 Baihe Recent Development
7.5 Aenova
7.5.1 Aenova Company Information
7.5.2 Aenova Business Overview
7.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Aenova Non-Animal Softgel Capsules Products Offered
7.5.5 Aenova Recent Development
7.6 Captek
7.6.1 Captek Company Information
7.6.2 Captek Business Overview
7.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Captek Non-Animal Softgel Capsules Products Offered
7.6.5 Captek Recent Development
7.7 Sirio
7.7.1 Sirio Company Information
7.7.2 Sirio Business Overview
7.7.3 Sirio Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Sirio Non-Animal Softgel Capsules Products Offered
7.7.5 Sirio Recent Development
7.8 Bahrain Pharma
7.8.1 Bahrain Pharma Company Information
7.8.2 Bahrain Pharma Business Overview
7.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Bahrain Pharma Non-Animal Softgel Capsules Products Offered
7.8.5 Bahrain Pharma Recent Development
7.9 Robinson Pharma
7.9.1 Robinson Pharma Company Information
7.9.2 Robinson Pharma Business Overview
7.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Robinson Pharma Non-Animal Softgel Capsules Products Offered
7.9.5 Robinson Pharma Recent Development
7.10 Aland
7.10.1 Aland Company Information
7.10.2 Aland Business Overview
7.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Aland Non-Animal Softgel Capsules Products Offered
7.10.5 Aland Recent Development
7.11 Fuji Capsule
7.11.1 Fuji Capsule Company Information
7.11.2 Fuji Capsule Business Overview
7.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Fuji Capsule Non-Animal Softgel Capsules Products Offered
7.11.5 Fuji Capsule Recent Development
7.12 Sunsho Pharmaceutical
7.12.1 Sunsho Pharmaceutical Company Information
7.12.2 Sunsho Pharmaceutical Business Overview
7.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Products Offered
7.12.5 Sunsho Pharmaceutical Recent Development
7.13 Erkang
7.13.1 Erkang Company Information
7.13.2 Erkang Business Overview
7.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Erkang Non-Animal Softgel Capsules Products Offered
7.13.5 Erkang Recent Development
8 Non-Animal Softgel Capsules Manufacturing Cost Analysis
8.1 Non-Animal Softgel Capsules Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Non-Animal Softgel Capsules
8.4 Non-Animal Softgel Capsules Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Non-Animal Softgel Capsules Distributors List
9.3 Non-Animal Softgel Capsules Customers
10 Non-Animal Softgel Capsules Market Dynamics
10.1 Non-Animal Softgel Capsules Industry Trends
10.2 Non-Animal Softgel Capsules Market Drivers
10.3 Non-Animal Softgel Capsules Market Challenges
10.4 Non-Animal Softgel Capsules Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Non-Animal Softgel Capsules Product Scope
1.2 Non-Animal Softgel Capsules by Type
1.2.1 Global Non-Animal Softgel Capsules Sales by Type (2020 & 2024 & 2031)
1.2.2 Carrageenan Softgel
1.2.3 Starch Softgel
1.2.4 Gellan Gum Softgel
1.3 Non-Animal Softgel Capsules by Application
1.3.1 Global Non-Animal Softgel Capsules Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Global Non-Animal Softgel Capsules Market Estimates and Forecasts (2020-2031)
1.4.1 Global Non-Animal Softgel Capsules Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Non-Animal Softgel Capsules Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Non-Animal Softgel Capsules Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Non-Animal Softgel Capsules Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Non-Animal Softgel Capsules Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Non-Animal Softgel Capsules Sales Market Share by Region (2020-2025)
2.2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Region (2020-2025)
2.3 Global Non-Animal Softgel Capsules Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Non-Animal Softgel Capsules Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Non-Animal Softgel Capsules Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Non-Animal Softgel Capsules Market Size and Prospective (2020-2031)
2.4.2 Europe Non-Animal Softgel Capsules Market Size and Prospective (2020-2031)
2.4.3 China Non-Animal Softgel Capsules Market Size and Prospective (2020-2031)
2.4.4 Japan Non-Animal Softgel Capsules Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Non-Animal Softgel Capsules Historic Market Review by Type (2020-2025)
3.1.1 Global Non-Animal Softgel Capsules Sales by Type (2020-2025)
3.1.2 Global Non-Animal Softgel Capsules Revenue by Type (2020-2025)
3.1.3 Global Non-Animal Softgel Capsules Price by Type (2020-2025)
3.2 Global Non-Animal Softgel Capsules Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Non-Animal Softgel Capsules Sales Forecast by Type (2026-2031)
3.2.2 Global Non-Animal Softgel Capsules Revenue Forecast by Type (2026-2031)
3.2.3 Global Non-Animal Softgel Capsules Price Forecast by Type (2026-2031)
3.3 Different Types Non-Animal Softgel Capsules Representative Players
4 Global Market Size by Application
4.1 Global Non-Animal Softgel Capsules Historic Market Review by Application (2020-2025)
4.1.1 Global Non-Animal Softgel Capsules Sales by Application (2020-2025)
4.1.2 Global Non-Animal Softgel Capsules Revenue by Application (2020-2025)
4.1.3 Global Non-Animal Softgel Capsules Price by Application (2020-2025)
4.2 Global Non-Animal Softgel Capsules Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Non-Animal Softgel Capsules Sales Forecast by Application (2026-2031)
4.2.2 Global Non-Animal Softgel Capsules Revenue Forecast by Application (2026-2031)
4.2.3 Global Non-Animal Softgel Capsules Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Non-Animal Softgel Capsules Application
5 Competition Landscape by Players
5.1 Global Non-Animal Softgel Capsules Sales by Players (2020-2025)
5.2 Global Top Non-Animal Softgel Capsules Players by Revenue (2020-2025)
5.3 Global Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Animal Softgel Capsules as of 2024)
5.4 Global Non-Animal Softgel Capsules Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Non-Animal Softgel Capsules, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Non-Animal Softgel Capsules, Product Type & Application
5.7 Global Key Manufacturers of Non-Animal Softgel Capsules, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Non-Animal Softgel Capsules Sales by Company
6.1.1.1 North America Non-Animal Softgel Capsules Sales by Company (2020-2025)
6.1.1.2 North America Non-Animal Softgel Capsules Revenue by Company (2020-2025)
6.1.2 North America Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
6.1.3 North America Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6.1.4 North America Non-Animal Softgel Capsules Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Non-Animal Softgel Capsules Sales by Company
6.2.1.1 Europe Non-Animal Softgel Capsules Sales by Company (2020-2025)
6.2.1.2 Europe Non-Animal Softgel Capsules Revenue by Company (2020-2025)
6.2.2 Europe Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
6.2.3 Europe Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6.2.4 Europe Non-Animal Softgel Capsules Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Non-Animal Softgel Capsules Sales by Company
6.3.1.1 China Non-Animal Softgel Capsules Sales by Company (2020-2025)
6.3.1.2 China Non-Animal Softgel Capsules Revenue by Company (2020-2025)
6.3.2 China Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
6.3.3 China Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6.3.4 China Non-Animal Softgel Capsules Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Non-Animal Softgel Capsules Sales by Company
6.4.1.1 Japan Non-Animal Softgel Capsules Sales by Company (2020-2025)
6.4.1.2 Japan Non-Animal Softgel Capsules Revenue by Company (2020-2025)
6.4.2 Japan Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
6.4.3 Japan Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6.4.4 Japan Non-Animal Softgel Capsules Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Catalent
7.1.1 Catalent Company Information
7.1.2 Catalent Business Overview
7.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Catalent Non-Animal Softgel Capsules Products Offered
7.1.5 Catalent Recent Development
7.2 Procaps Laboratorios
7.2.1 Procaps Laboratorios Company Information
7.2.2 Procaps Laboratorios Business Overview
7.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Products Offered
7.2.5 Procaps Laboratorios Recent Development
7.3 EuroCaps
7.3.1 EuroCaps Company Information
7.3.2 EuroCaps Business Overview
7.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.3.4 EuroCaps Non-Animal Softgel Capsules Products Offered
7.3.5 EuroCaps Recent Development
7.4 Baihe
7.4.1 Baihe Company Information
7.4.2 Baihe Business Overview
7.4.3 Baihe Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Baihe Non-Animal Softgel Capsules Products Offered
7.4.5 Baihe Recent Development
7.5 Aenova
7.5.1 Aenova Company Information
7.5.2 Aenova Business Overview
7.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Aenova Non-Animal Softgel Capsules Products Offered
7.5.5 Aenova Recent Development
7.6 Captek
7.6.1 Captek Company Information
7.6.2 Captek Business Overview
7.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Captek Non-Animal Softgel Capsules Products Offered
7.6.5 Captek Recent Development
7.7 Sirio
7.7.1 Sirio Company Information
7.7.2 Sirio Business Overview
7.7.3 Sirio Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Sirio Non-Animal Softgel Capsules Products Offered
7.7.5 Sirio Recent Development
7.8 Bahrain Pharma
7.8.1 Bahrain Pharma Company Information
7.8.2 Bahrain Pharma Business Overview
7.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Bahrain Pharma Non-Animal Softgel Capsules Products Offered
7.8.5 Bahrain Pharma Recent Development
7.9 Robinson Pharma
7.9.1 Robinson Pharma Company Information
7.9.2 Robinson Pharma Business Overview
7.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Robinson Pharma Non-Animal Softgel Capsules Products Offered
7.9.5 Robinson Pharma Recent Development
7.10 Aland
7.10.1 Aland Company Information
7.10.2 Aland Business Overview
7.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Aland Non-Animal Softgel Capsules Products Offered
7.10.5 Aland Recent Development
7.11 Fuji Capsule
7.11.1 Fuji Capsule Company Information
7.11.2 Fuji Capsule Business Overview
7.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Fuji Capsule Non-Animal Softgel Capsules Products Offered
7.11.5 Fuji Capsule Recent Development
7.12 Sunsho Pharmaceutical
7.12.1 Sunsho Pharmaceutical Company Information
7.12.2 Sunsho Pharmaceutical Business Overview
7.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Products Offered
7.12.5 Sunsho Pharmaceutical Recent Development
7.13 Erkang
7.13.1 Erkang Company Information
7.13.2 Erkang Business Overview
7.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Erkang Non-Animal Softgel Capsules Products Offered
7.13.5 Erkang Recent Development
8 Non-Animal Softgel Capsules Manufacturing Cost Analysis
8.1 Non-Animal Softgel Capsules Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Non-Animal Softgel Capsules
8.4 Non-Animal Softgel Capsules Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Non-Animal Softgel Capsules Distributors List
9.3 Non-Animal Softgel Capsules Customers
10 Non-Animal Softgel Capsules Market Dynamics
10.1 Non-Animal Softgel Capsules Industry Trends
10.2 Non-Animal Softgel Capsules Market Drivers
10.3 Non-Animal Softgel Capsules Market Challenges
10.4 Non-Animal Softgel Capsules Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Non-Animal Softgel Capsules Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Non-Animal Softgel Capsules Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Non-Animal Softgel Capsules Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Non-Animal Softgel Capsules Sales (M Capsules) by Region (2020-2025)
Table 5. Global Non-Animal Softgel Capsules Sales Market Share by Region (2020-2025)
Table 6. Global Non-Animal Softgel Capsules Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Non-Animal Softgel Capsules Revenue Share by Region (2020-2025)
Table 8. Global Non-Animal Softgel Capsules Sales (M Capsules) Forecast by Region (2026-2031)
Table 9. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Non-Animal Softgel Capsules Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Non-Animal Softgel Capsules Revenue Share Forecast by Region (2026-2031)
Table 12. Global Non-Animal Softgel Capsules Sales by Type (M Capsules) & (2020-2025)
Table 13. Global Non-Animal Softgel Capsules Sales Share by Type (2020-2025)
Table 14. Global Non-Animal Softgel Capsules Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Non-Animal Softgel Capsules Price by Type (US$/Capsule) & (2020-2025)
Table 16. Global Non-Animal Softgel Capsules Sales by Type (M Capsules) & (2026-2031)
Table 17. Global Non-Animal Softgel Capsules Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Non-Animal Softgel Capsules Price by Type (US$/Capsule) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Non-Animal Softgel Capsules Sales by Application (M Capsules) & (2020-2025)
Table 21. Global Non-Animal Softgel Capsules Sales Share by Application (2020-2025)
Table 22. Global Non-Animal Softgel Capsules Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Non-Animal Softgel Capsules Price by Application (US$/Capsule) & (2020-2025)
Table 24. Global Non-Animal Softgel Capsules Sales by Application (M Capsules) & (2026-2031)
Table 25. Global Non-Animal Softgel Capsules Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Non-Animal Softgel Capsules Price by Application (US$/Capsule) & (2026-2031)
Table 27. New Sources of Growth in Non-Animal Softgel Capsules Application
Table 28. Global Non-Animal Softgel Capsules Sales by Company (M Capsules) & (2020-2025)
Table 29. Global Non-Animal Softgel Capsules Sales Share by Company (2020-2025)
Table 30. Global Non-Animal Softgel Capsules Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Non-Animal Softgel Capsules Revenue Share by Company (2020-2025)
Table 32. Global Non-Animal Softgel Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Animal Softgel Capsules as of 2024)
Table 33. Global Market Non-Animal Softgel Capsules Average Price by Company (US$/Capsule) & (2020-2025)
Table 34. Global Key Manufacturers of Non-Animal Softgel Capsules, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Non-Animal Softgel Capsules, Product Type & Application
Table 36. Global Key Manufacturers of Non-Animal Softgel Capsules, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Non-Animal Softgel Capsules Sales by Company (2020-2025) & (M Capsules)
Table 39. North America Non-Animal Softgel Capsules Sales Market Share by Company (2020-2025)
Table 40. North America Non-Animal Softgel Capsules Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2025)
Table 42. North America Non-Animal Softgel Capsules Sales by Type (2020-2025) & (M Capsules)
Table 43. North America Non-Animal Softgel Capsules Sales Market Share by Type (2020-2025)
Table 44. North America Non-Animal Softgel Capsules Sales by Application (2020-2025) & (M Capsules)
Table 45. North America Non-Animal Softgel Capsules Sales Market Share by Application (2020-2025)
Table 46. Europe Non-Animal Softgel Capsules Sales by Company (2020-2025) & (M Capsules)
Table 47. Europe Non-Animal Softgel Capsules Sales Market Share by Company (2020-2025)
Table 48. Europe Non-Animal Softgel Capsules Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2025)
Table 50. Europe Non-Animal Softgel Capsules Sales by Type (2020-2025) & (M Capsules)
Table 51. Europe Non-Animal Softgel Capsules Sales Market Share by Type (2020-2025)
Table 52. Europe Non-Animal Softgel Capsules Sales by Application (2020-2025) & (M Capsules)
Table 53. Europe Non-Animal Softgel Capsules Sales Market Share by Application (2020-2025)
Table 54. China Non-Animal Softgel Capsules Sales by Company (2020-2025) & (M Capsules)
Table 55. China Non-Animal Softgel Capsules Sales Market Share by Company (2020-2025)
Table 56. China Non-Animal Softgel Capsules Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2025)
Table 58. China Non-Animal Softgel Capsules Sales by Type (2020-2025) & (M Capsules)
Table 59. China Non-Animal Softgel Capsules Sales Market Share by Type (2020-2025)
Table 60. China Non-Animal Softgel Capsules Sales by Application (2020-2025) & (M Capsules)
Table 61. China Non-Animal Softgel Capsules Sales Market Share by Application (2020-2025)
Table 62. Japan Non-Animal Softgel Capsules Sales by Company (2020-2025) & (M Capsules)
Table 63. Japan Non-Animal Softgel Capsules Sales Market Share by Company (2020-2025)
Table 64. Japan Non-Animal Softgel Capsules Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2025)
Table 66. Japan Non-Animal Softgel Capsules Sales by Type (2020-2025) & (M Capsules)
Table 67. Japan Non-Animal Softgel Capsules Sales Market Share by Type (2020-2025)
Table 68. Japan Non-Animal Softgel Capsules Sales by Application (2020-2025) & (M Capsules)
Table 69. Japan Non-Animal Softgel Capsules Sales Market Share by Application (2020-2025)
Table 70. Catalent Company Information
Table 71. Catalent Description and Business Overview
Table 72. Catalent Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 73. Catalent Non-Animal Softgel Capsules Product
Table 74. Catalent Recent Development
Table 75. Procaps Laboratorios Company Information
Table 76. Procaps Laboratorios Description and Business Overview
Table 77. Procaps Laboratorios Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 78. Procaps Laboratorios Non-Animal Softgel Capsules Product
Table 79. Procaps Laboratorios Recent Development
Table 80. EuroCaps Company Information
Table 81. EuroCaps Description and Business Overview
Table 82. EuroCaps Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 83. EuroCaps Non-Animal Softgel Capsules Product
Table 84. EuroCaps Recent Development
Table 85. Baihe Company Information
Table 86. Baihe Description and Business Overview
Table 87. Baihe Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 88. Baihe Non-Animal Softgel Capsules Product
Table 89. Baihe Recent Development
Table 90. Aenova Company Information
Table 91. Aenova Description and Business Overview
Table 92. Aenova Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 93. Aenova Non-Animal Softgel Capsules Product
Table 94. Aenova Recent Development
Table 95. Captek Company Information
Table 96. Captek Description and Business Overview
Table 97. Captek Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 98. Captek Non-Animal Softgel Capsules Product
Table 99. Captek Recent Development
Table 100. Sirio Company Information
Table 101. Sirio Description and Business Overview
Table 102. Sirio Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 103. Sirio Non-Animal Softgel Capsules Product
Table 104. Sirio Recent Development
Table 105. Bahrain Pharma Company Information
Table 106. Bahrain Pharma Description and Business Overview
Table 107. Bahrain Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 108. Bahrain Pharma Non-Animal Softgel Capsules Product
Table 109. Bahrain Pharma Recent Development
Table 110. Robinson Pharma Company Information
Table 111. Robinson Pharma Description and Business Overview
Table 112. Robinson Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 113. Robinson Pharma Non-Animal Softgel Capsules Product
Table 114. Robinson Pharma Recent Development
Table 115. Aland Company Information
Table 116. Aland Description and Business Overview
Table 117. Aland Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 118. Aland Non-Animal Softgel Capsules Product
Table 119. Aland Recent Development
Table 120. Fuji Capsule Company Information
Table 121. Fuji Capsule Description and Business Overview
Table 122. Fuji Capsule Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 123. Fuji Capsule Non-Animal Softgel Capsules Product
Table 124. Fuji Capsule Recent Development
Table 125. Sunsho Pharmaceutical Company Information
Table 126. Sunsho Pharmaceutical Description and Business Overview
Table 127. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 128. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product
Table 129. Sunsho Pharmaceutical Recent Development
Table 130. Erkang Company Information
Table 131. Erkang Description and Business Overview
Table 132. Erkang Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 133. Erkang Non-Animal Softgel Capsules Product
Table 134. Erkang Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Non-Animal Softgel Capsules Distributors List
Table 138. Non-Animal Softgel Capsules Customers List
Table 139. Non-Animal Softgel Capsules Market Trends
Table 140. Non-Animal Softgel Capsules Market Drivers
Table 141. Non-Animal Softgel Capsules Market Challenges
Table 142. Non-Animal Softgel Capsules Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Animal Softgel Capsules Product Picture
Figure 2. Global Non-Animal Softgel Capsules Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Non-Animal Softgel Capsules Sales Market Share by Type in 2024 & 2031
Figure 4. Carrageenan Softgel Product Picture
Figure 5. Starch Softgel Product Picture
Figure 6. Gellan Gum Softgel Product Picture
Figure 7. Global Non-Animal Softgel Capsules Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Non-Animal Softgel Capsules Sales Market Share by Application in 2024 & 2031
Figure 9. Health Supplements Examples
Figure 10. Pharmaceutical Examples
Figure 11. Others Examples
Figure 12. Global Non-Animal Softgel Capsules Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Non-Animal Softgel Capsules Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 15. Global Non-Animal Softgel Capsules Price Trends Growth Rate (2020-2031) & (US$/Capsule)
Figure 16. Non-Animal Softgel Capsules Report Years Considered
Figure 17. Global Market Non-Animal Softgel Capsules Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Non-Animal Softgel Capsules Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Non-Animal Softgel Capsules Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 21. Europe Non-Animal Softgel Capsules Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 23. China Non-Animal Softgel Capsules Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 25. Japan Non-Animal Softgel Capsules Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 27. Global Non-Animal Softgel Capsules Revenue Share by Type (2020-2025)
Figure 28. Global Non-Animal Softgel Capsules Sales Share by Type (2026-2031)
Figure 29. Global Non-Animal Softgel Capsules Revenue Share by Type (2026-2031)
Figure 30. Global Non-Animal Softgel Capsules Revenue Share by Application (2020-2025)
Figure 31. Global Non-Animal Softgel Capsules Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Non-Animal Softgel Capsules Sales Share by Application (2026-2031)
Figure 33. Global Non-Animal Softgel Capsules Revenue Share by Application (2026-2031)
Figure 34. Global Non-Animal Softgel Capsules Sales Share by Company (2024)
Figure 35. Global Non-Animal Softgel Capsules Revenue Share by Company (2024)
Figure 36. Global 5 Largest Non-Animal Softgel Capsules Players Market Share by Revenue in Non-Animal Softgel Capsules: 2020 & 2024
Figure 37. Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Non-Animal Softgel Capsules
Figure 39. Manufacturing Process Analysis of Non-Animal Softgel Capsules
Figure 40. Non-Animal Softgel Capsules Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Table 1. Global Non-Animal Softgel Capsules Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Non-Animal Softgel Capsules Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Non-Animal Softgel Capsules Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Non-Animal Softgel Capsules Sales (M Capsules) by Region (2020-2025)
Table 5. Global Non-Animal Softgel Capsules Sales Market Share by Region (2020-2025)
Table 6. Global Non-Animal Softgel Capsules Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Non-Animal Softgel Capsules Revenue Share by Region (2020-2025)
Table 8. Global Non-Animal Softgel Capsules Sales (M Capsules) Forecast by Region (2026-2031)
Table 9. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Non-Animal Softgel Capsules Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Non-Animal Softgel Capsules Revenue Share Forecast by Region (2026-2031)
Table 12. Global Non-Animal Softgel Capsules Sales by Type (M Capsules) & (2020-2025)
Table 13. Global Non-Animal Softgel Capsules Sales Share by Type (2020-2025)
Table 14. Global Non-Animal Softgel Capsules Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Non-Animal Softgel Capsules Price by Type (US$/Capsule) & (2020-2025)
Table 16. Global Non-Animal Softgel Capsules Sales by Type (M Capsules) & (2026-2031)
Table 17. Global Non-Animal Softgel Capsules Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Non-Animal Softgel Capsules Price by Type (US$/Capsule) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Non-Animal Softgel Capsules Sales by Application (M Capsules) & (2020-2025)
Table 21. Global Non-Animal Softgel Capsules Sales Share by Application (2020-2025)
Table 22. Global Non-Animal Softgel Capsules Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Non-Animal Softgel Capsules Price by Application (US$/Capsule) & (2020-2025)
Table 24. Global Non-Animal Softgel Capsules Sales by Application (M Capsules) & (2026-2031)
Table 25. Global Non-Animal Softgel Capsules Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Non-Animal Softgel Capsules Price by Application (US$/Capsule) & (2026-2031)
Table 27. New Sources of Growth in Non-Animal Softgel Capsules Application
Table 28. Global Non-Animal Softgel Capsules Sales by Company (M Capsules) & (2020-2025)
Table 29. Global Non-Animal Softgel Capsules Sales Share by Company (2020-2025)
Table 30. Global Non-Animal Softgel Capsules Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Non-Animal Softgel Capsules Revenue Share by Company (2020-2025)
Table 32. Global Non-Animal Softgel Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Animal Softgel Capsules as of 2024)
Table 33. Global Market Non-Animal Softgel Capsules Average Price by Company (US$/Capsule) & (2020-2025)
Table 34. Global Key Manufacturers of Non-Animal Softgel Capsules, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Non-Animal Softgel Capsules, Product Type & Application
Table 36. Global Key Manufacturers of Non-Animal Softgel Capsules, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Non-Animal Softgel Capsules Sales by Company (2020-2025) & (M Capsules)
Table 39. North America Non-Animal Softgel Capsules Sales Market Share by Company (2020-2025)
Table 40. North America Non-Animal Softgel Capsules Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2025)
Table 42. North America Non-Animal Softgel Capsules Sales by Type (2020-2025) & (M Capsules)
Table 43. North America Non-Animal Softgel Capsules Sales Market Share by Type (2020-2025)
Table 44. North America Non-Animal Softgel Capsules Sales by Application (2020-2025) & (M Capsules)
Table 45. North America Non-Animal Softgel Capsules Sales Market Share by Application (2020-2025)
Table 46. Europe Non-Animal Softgel Capsules Sales by Company (2020-2025) & (M Capsules)
Table 47. Europe Non-Animal Softgel Capsules Sales Market Share by Company (2020-2025)
Table 48. Europe Non-Animal Softgel Capsules Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2025)
Table 50. Europe Non-Animal Softgel Capsules Sales by Type (2020-2025) & (M Capsules)
Table 51. Europe Non-Animal Softgel Capsules Sales Market Share by Type (2020-2025)
Table 52. Europe Non-Animal Softgel Capsules Sales by Application (2020-2025) & (M Capsules)
Table 53. Europe Non-Animal Softgel Capsules Sales Market Share by Application (2020-2025)
Table 54. China Non-Animal Softgel Capsules Sales by Company (2020-2025) & (M Capsules)
Table 55. China Non-Animal Softgel Capsules Sales Market Share by Company (2020-2025)
Table 56. China Non-Animal Softgel Capsules Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2025)
Table 58. China Non-Animal Softgel Capsules Sales by Type (2020-2025) & (M Capsules)
Table 59. China Non-Animal Softgel Capsules Sales Market Share by Type (2020-2025)
Table 60. China Non-Animal Softgel Capsules Sales by Application (2020-2025) & (M Capsules)
Table 61. China Non-Animal Softgel Capsules Sales Market Share by Application (2020-2025)
Table 62. Japan Non-Animal Softgel Capsules Sales by Company (2020-2025) & (M Capsules)
Table 63. Japan Non-Animal Softgel Capsules Sales Market Share by Company (2020-2025)
Table 64. Japan Non-Animal Softgel Capsules Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2025)
Table 66. Japan Non-Animal Softgel Capsules Sales by Type (2020-2025) & (M Capsules)
Table 67. Japan Non-Animal Softgel Capsules Sales Market Share by Type (2020-2025)
Table 68. Japan Non-Animal Softgel Capsules Sales by Application (2020-2025) & (M Capsules)
Table 69. Japan Non-Animal Softgel Capsules Sales Market Share by Application (2020-2025)
Table 70. Catalent Company Information
Table 71. Catalent Description and Business Overview
Table 72. Catalent Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 73. Catalent Non-Animal Softgel Capsules Product
Table 74. Catalent Recent Development
Table 75. Procaps Laboratorios Company Information
Table 76. Procaps Laboratorios Description and Business Overview
Table 77. Procaps Laboratorios Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 78. Procaps Laboratorios Non-Animal Softgel Capsules Product
Table 79. Procaps Laboratorios Recent Development
Table 80. EuroCaps Company Information
Table 81. EuroCaps Description and Business Overview
Table 82. EuroCaps Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 83. EuroCaps Non-Animal Softgel Capsules Product
Table 84. EuroCaps Recent Development
Table 85. Baihe Company Information
Table 86. Baihe Description and Business Overview
Table 87. Baihe Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 88. Baihe Non-Animal Softgel Capsules Product
Table 89. Baihe Recent Development
Table 90. Aenova Company Information
Table 91. Aenova Description and Business Overview
Table 92. Aenova Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 93. Aenova Non-Animal Softgel Capsules Product
Table 94. Aenova Recent Development
Table 95. Captek Company Information
Table 96. Captek Description and Business Overview
Table 97. Captek Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 98. Captek Non-Animal Softgel Capsules Product
Table 99. Captek Recent Development
Table 100. Sirio Company Information
Table 101. Sirio Description and Business Overview
Table 102. Sirio Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 103. Sirio Non-Animal Softgel Capsules Product
Table 104. Sirio Recent Development
Table 105. Bahrain Pharma Company Information
Table 106. Bahrain Pharma Description and Business Overview
Table 107. Bahrain Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 108. Bahrain Pharma Non-Animal Softgel Capsules Product
Table 109. Bahrain Pharma Recent Development
Table 110. Robinson Pharma Company Information
Table 111. Robinson Pharma Description and Business Overview
Table 112. Robinson Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 113. Robinson Pharma Non-Animal Softgel Capsules Product
Table 114. Robinson Pharma Recent Development
Table 115. Aland Company Information
Table 116. Aland Description and Business Overview
Table 117. Aland Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 118. Aland Non-Animal Softgel Capsules Product
Table 119. Aland Recent Development
Table 120. Fuji Capsule Company Information
Table 121. Fuji Capsule Description and Business Overview
Table 122. Fuji Capsule Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 123. Fuji Capsule Non-Animal Softgel Capsules Product
Table 124. Fuji Capsule Recent Development
Table 125. Sunsho Pharmaceutical Company Information
Table 126. Sunsho Pharmaceutical Description and Business Overview
Table 127. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 128. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product
Table 129. Sunsho Pharmaceutical Recent Development
Table 130. Erkang Company Information
Table 131. Erkang Description and Business Overview
Table 132. Erkang Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule) and Gross Margin (2020-2025)
Table 133. Erkang Non-Animal Softgel Capsules Product
Table 134. Erkang Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Non-Animal Softgel Capsules Distributors List
Table 138. Non-Animal Softgel Capsules Customers List
Table 139. Non-Animal Softgel Capsules Market Trends
Table 140. Non-Animal Softgel Capsules Market Drivers
Table 141. Non-Animal Softgel Capsules Market Challenges
Table 142. Non-Animal Softgel Capsules Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Animal Softgel Capsules Product Picture
Figure 2. Global Non-Animal Softgel Capsules Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Non-Animal Softgel Capsules Sales Market Share by Type in 2024 & 2031
Figure 4. Carrageenan Softgel Product Picture
Figure 5. Starch Softgel Product Picture
Figure 6. Gellan Gum Softgel Product Picture
Figure 7. Global Non-Animal Softgel Capsules Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Non-Animal Softgel Capsules Sales Market Share by Application in 2024 & 2031
Figure 9. Health Supplements Examples
Figure 10. Pharmaceutical Examples
Figure 11. Others Examples
Figure 12. Global Non-Animal Softgel Capsules Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Non-Animal Softgel Capsules Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 15. Global Non-Animal Softgel Capsules Price Trends Growth Rate (2020-2031) & (US$/Capsule)
Figure 16. Non-Animal Softgel Capsules Report Years Considered
Figure 17. Global Market Non-Animal Softgel Capsules Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Non-Animal Softgel Capsules Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Non-Animal Softgel Capsules Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 21. Europe Non-Animal Softgel Capsules Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 23. China Non-Animal Softgel Capsules Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 25. Japan Non-Animal Softgel Capsules Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate (2020-2031)
Figure 27. Global Non-Animal Softgel Capsules Revenue Share by Type (2020-2025)
Figure 28. Global Non-Animal Softgel Capsules Sales Share by Type (2026-2031)
Figure 29. Global Non-Animal Softgel Capsules Revenue Share by Type (2026-2031)
Figure 30. Global Non-Animal Softgel Capsules Revenue Share by Application (2020-2025)
Figure 31. Global Non-Animal Softgel Capsules Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Non-Animal Softgel Capsules Sales Share by Application (2026-2031)
Figure 33. Global Non-Animal Softgel Capsules Revenue Share by Application (2026-2031)
Figure 34. Global Non-Animal Softgel Capsules Sales Share by Company (2024)
Figure 35. Global Non-Animal Softgel Capsules Revenue Share by Company (2024)
Figure 36. Global 5 Largest Non-Animal Softgel Capsules Players Market Share by Revenue in Non-Animal Softgel Capsules: 2020 & 2024
Figure 37. Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Non-Animal Softgel Capsules
Figure 39. Manufacturing Process Analysis of Non-Animal Softgel Capsules
Figure 40. Non-Animal Softgel Capsules Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232